Artificial intelligence spots hidden liver scarring from simple blood tests

NCT ID NCT07675525

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests a computer program called NIMIT-AI that analyzes routine blood test results over multiple doctor visits to detect liver scarring in people with fatty liver disease (MASLD). Unlike the current standard method (FIB-4), which often misses cases and fails with incomplete data, NIMIT-AI uses deep learning to spot patterns suggesting fibrosis. The tool was developed using health records from 969 patients at a Thai hospital and showed better accuracy than FIB-4, even when some lab results were missing. No extra tests or procedures were required from patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NIMIT-AI (artificial intelligence diagnostic model)
What this could lead to
If successful, this AI tool could help doctors catch liver scarring earlier in fatty liver disease patients, potentially preventing progression to severe liver damage.
What could go wrong
This is a retrospective study using data from one hospital in Thailand, so results may not apply to other populations. The AI needs prospective validation before clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD - METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Faculty of Medicine Siriraj Hospital

    Bangkok Noi, Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.